nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciprofloxacin—Epidermolysis—Dactinomycin—ocular cancer	0.109	0.352	CcSEcCtD
Ciprofloxacin—TOP2A—G0 and Early G1—E2F5—ocular cancer	0.0308	0.0446	CbGpPWpGaD
Ciprofloxacin—TOP2A—G0 and Early G1—E2F4—ocular cancer	0.0302	0.0437	CbGpPWpGaD
Ciprofloxacin—TOP2A—G0 and Early G1—MYBL2—ocular cancer	0.0302	0.0437	CbGpPWpGaD
Ciprofloxacin—TOP2A—G0 and Early G1—RBL1—ocular cancer	0.0296	0.0428	CbGpPWpGaD
Ciprofloxacin—TOP2A—G0 and Early G1—RBL2—ocular cancer	0.0272	0.0393	CbGpPWpGaD
Ciprofloxacin—TOP2A—Gastric Cancer Network 1—MYBL2—ocular cancer	0.0268	0.0388	CbGpPWpGaD
Ciprofloxacin—TOP2A—G0 and Early G1—RBBP4—ocular cancer	0.0257	0.0371	CbGpPWpGaD
Ciprofloxacin—TOP2A—G0 and Early G1—CDC25A—ocular cancer	0.0244	0.0353	CbGpPWpGaD
Ciprofloxacin—TOP2A—G0 and Early G1—TFDP1—ocular cancer	0.0239	0.0345	CbGpPWpGaD
Ciprofloxacin—Extravasation—Carboplatin—ocular cancer	0.0161	0.052	CcSEcCtD
Ciprofloxacin—TOP2A—G0 and Early G1—HDAC1—ocular cancer	0.0139	0.0201	CbGpPWpGaD
Ciprofloxacin—Phlebitis—Carboplatin—ocular cancer	0.0118	0.0382	CcSEcCtD
Ciprofloxacin—TOP2A—G0 and Early G1—E2F1—ocular cancer	0.0114	0.0165	CbGpPWpGaD
Ciprofloxacin—Ulcerative stomatitis—Dactinomycin—ocular cancer	0.0113	0.0365	CcSEcCtD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—E2F2—ocular cancer	0.0109	0.0158	CbGpPWpGaD
Ciprofloxacin—TOP2A—G0 and Early G1—CDK2—ocular cancer	0.00984	0.0142	CbGpPWpGaD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2C—ocular cancer	0.00961	0.0139	CbGpPWpGaD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—E2F3—ocular cancer	0.00947	0.0137	CbGpPWpGaD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RBBP4—ocular cancer	0.00947	0.0137	CbGpPWpGaD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDC25A—ocular cancer	0.009	0.013	CbGpPWpGaD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TFDP1—ocular cancer	0.0088	0.0127	CbGpPWpGaD
Ciprofloxacin—Eruption—Dactinomycin—ocular cancer	0.00845	0.0274	CcSEcCtD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—E2F5—ocular cancer	0.008	0.0116	CbGpPWpGaD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND3—ocular cancer	0.00798	0.0115	CbGpPWpGaD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—E2F4—ocular cancer	0.00783	0.0113	CbGpPWpGaD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—MYBL2—ocular cancer	0.00783	0.0113	CbGpPWpGaD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—RBL1—ocular cancer	0.00768	0.0111	CbGpPWpGaD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—E2F2—ocular cancer	0.00768	0.0111	CbGpPWpGaD
Ciprofloxacin—Hepatomegaly—Dactinomycin—ocular cancer	0.00735	0.0238	CcSEcCtD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—RBL2—ocular cancer	0.00705	0.0102	CbGpPWpGaD
Ciprofloxacin—TOP2A—Circadian rythm related genes—CRTC1—ocular cancer	0.00699	0.0101	CbGpPWpGaD
Ciprofloxacin—Coagulopathy—Dactinomycin—ocular cancer	0.00668	0.0216	CcSEcCtD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—RBBP4—ocular cancer	0.00666	0.00964	CbGpPWpGaD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—E2F3—ocular cancer	0.00666	0.00964	CbGpPWpGaD
Ciprofloxacin—Necrosis—Dactinomycin—ocular cancer	0.00662	0.0215	CcSEcCtD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—CDC25A—ocular cancer	0.00634	0.00916	CbGpPWpGaD
Ciprofloxacin—TOP2A—Circadian rythm related genes—ID2—ocular cancer	0.00623	0.00901	CbGpPWpGaD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—TFDP1—ocular cancer	0.00619	0.00896	CbGpPWpGaD
Ciprofloxacin—Extravasation—Dactinomycin—ocular cancer	0.00596	0.0193	CcSEcCtD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK6—ocular cancer	0.00594	0.0086	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.00594	0.00859	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.00582	0.00842	CbGpPWpGaD
Ciprofloxacin—Hypocalcaemia—Dactinomycin—ocular cancer	0.00568	0.0184	CcSEcCtD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—CCND3—ocular cancer	0.00561	0.00812	CbGpPWpGaD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—HDAC1—ocular cancer	0.00511	0.00739	CbGpPWpGaD
Ciprofloxacin—ABCB1—HIF-1-alpha transcription factor network—ID2—ocular cancer	0.005	0.00723	CbGpPWpGaD
Ciprofloxacin—Oesophagitis—Dactinomycin—ocular cancer	0.00475	0.0154	CcSEcCtD
Ciprofloxacin—Mouth ulceration—Dactinomycin—ocular cancer	0.0047	0.0152	CcSEcCtD
Ciprofloxacin—Sepsis—Dactinomycin—ocular cancer	0.00451	0.0146	CcSEcCtD
Ciprofloxacin—Phlebitis—Dactinomycin—ocular cancer	0.00438	0.0142	CcSEcCtD
Ciprofloxacin—Pain—Carboplatin—ocular cancer	0.00427	0.0138	CcSEcCtD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—E2F1—ocular cancer	0.00421	0.00608	CbGpPWpGaD
Ciprofloxacin—Hepatic failure—Dactinomycin—ocular cancer	0.0042	0.0136	CcSEcCtD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—CDK6—ocular cancer	0.00418	0.00605	CbGpPWpGaD
Ciprofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—ocular cancer	0.00416	0.00602	CbGpPWpGaD
Ciprofloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CCND3—ocular cancer	0.00416	0.00602	CbGpPWpGaD
Ciprofloxacin—TOP2A—Gastric Cancer Network 2—MYC—ocular cancer	0.00405	0.00587	CbGpPWpGaD
Ciprofloxacin—Body temperature increased—Carboplatin—ocular cancer	0.00395	0.0128	CcSEcCtD
Ciprofloxacin—Lethargy—Dactinomycin—ocular cancer	0.00385	0.0125	CcSEcCtD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK2—ocular cancer	0.00363	0.00525	CbGpPWpGaD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—CCND2—ocular cancer	0.0036	0.0052	CbGpPWpGaD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—HDAC1—ocular cancer	0.0036	0.0052	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2C—ocular cancer	0.00352	0.0051	CbGpPWpGaD
Ciprofloxacin—Liver function test abnormal—Dactinomycin—ocular cancer	0.00348	0.0113	CcSEcCtD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—ocular cancer	0.00343	0.00496	CbGpPWpGaD
Ciprofloxacin—Toxic epidermal necrolysis—Dactinomycin—ocular cancer	0.0034	0.011	CcSEcCtD
Ciprofloxacin—Aspartate aminotransferase increased—Dactinomycin—ocular cancer	0.0034	0.011	CcSEcCtD
Ciprofloxacin—TOP2A—Gastric Cancer Network 2—TP53—ocular cancer	0.00333	0.00482	CbGpPWpGaD
Ciprofloxacin—Dysphagia—Dactinomycin—ocular cancer	0.00326	0.0106	CcSEcCtD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2B—ocular cancer	0.00322	0.00466	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—CDKN2C—ocular cancer	0.00315	0.00456	CbGpPWpGaD
Ciprofloxacin—TOP2A—Circadian rythm related genes—GNA11—ocular cancer	0.00312	0.00452	CbGpPWpGaD
Ciprofloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—ocular cancer	0.0031	0.00448	CbGpPWpGaD
Ciprofloxacin—Pancytopenia—Dactinomycin—ocular cancer	0.0031	0.01	CcSEcCtD
Ciprofloxacin—Neutropenia—Dactinomycin—ocular cancer	0.00305	0.00988	CcSEcCtD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—ocular cancer	0.00298	0.00431	CbGpPWpGaD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—E2F1—ocular cancer	0.00296	0.00428	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—E2F5—ocular cancer	0.00293	0.00424	CbGpPWpGaD
Ciprofloxacin—Pneumonia—Dactinomycin—ocular cancer	0.00293	0.00948	CcSEcCtD
Ciprofloxacin—TOP2A—Circadian rythm related genes—GNAQ—ocular cancer	0.0029	0.0042	CbGpPWpGaD
Ciprofloxacin—Stevens-Johnson syndrome—Dactinomycin—ocular cancer	0.00288	0.00934	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—MYBL2—ocular cancer	0.00287	0.00416	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—E2F4—ocular cancer	0.00287	0.00416	CbGpPWpGaD
Ciprofloxacin—Stomatitis—Dactinomycin—ocular cancer	0.00284	0.00919	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—RBL1—ocular cancer	0.00282	0.00408	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—E2F2—ocular cancer	0.00282	0.00408	CbGpPWpGaD
Ciprofloxacin—Agranulocytosis—Dactinomycin—ocular cancer	0.00271	0.00879	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle—E2F5—ocular cancer	0.00262	0.00379	CbGpPWpGaD
Ciprofloxacin—TOP2A—Circadian rythm related genes—HDAC1—ocular cancer	0.00262	0.00378	CbGpPWpGaD
Ciprofloxacin—Hepatitis—Dactinomycin—ocular cancer	0.00261	0.00846	CcSEcCtD
Ciprofloxacin—Pharyngitis—Dactinomycin—ocular cancer	0.00259	0.0084	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—RBL2—ocular cancer	0.00259	0.00374	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—E2F4—ocular cancer	0.00257	0.00372	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—MYBL2—ocular cancer	0.00257	0.00372	CbGpPWpGaD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—CDK2—ocular cancer	0.00255	0.00369	CbGpPWpGaD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—ocular cancer	0.00254	0.00368	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—E2F2—ocular cancer	0.00252	0.00364	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—RBL1—ocular cancer	0.00252	0.00364	CbGpPWpGaD
Ciprofloxacin—Erythema multiforme—Dactinomycin—ocular cancer	0.00247	0.008	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—E2F3—ocular cancer	0.00244	0.00353	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—RBBP4—ocular cancer	0.00244	0.00353	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00244	0.00353	CbGpPWpGaD
Ciprofloxacin—Flushing—Dactinomycin—ocular cancer	0.00242	0.00785	CcSEcCtD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—CDK4—ocular cancer	0.00241	0.00349	CbGpPWpGaD
Ciprofloxacin—Chills—Dactinomycin—ocular cancer	0.00234	0.00759	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.00232	0.00336	CbGpPWpGaD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—ocular cancer	0.00232	0.00336	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—RBL2—ocular cancer	0.00231	0.00335	CbGpPWpGaD
Ciprofloxacin—Alopecia—Dactinomycin—ocular cancer	0.00231	0.00748	CcSEcCtD
Ciprofloxacin—Erythema—Dactinomycin—ocular cancer	0.00227	0.00736	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.00227	0.00329	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00224	0.00324	CbGpPWpGaD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	0.00221	0.0032	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—RBBP4—ocular cancer	0.00218	0.00316	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—E2F3—ocular cancer	0.00218	0.00316	CbGpPWpGaD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	0.00214	0.0031	CbGpPWpGaD
Ciprofloxacin—Ill-defined disorder—Dactinomycin—ocular cancer	0.00211	0.00683	CcSEcCtD
Ciprofloxacin—Anaemia—Dactinomycin—ocular cancer	0.0021	0.00681	CcSEcCtD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—RB1—ocular cancer	0.0021	0.00303	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—CDC25A—ocular cancer	0.00208	0.00301	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—CCND3—ocular cancer	0.00206	0.00298	CbGpPWpGaD
Ciprofloxacin—Malaise—Dactinomycin—ocular cancer	0.00205	0.00664	CcSEcCtD
Ciprofloxacin—Leukopenia—Dactinomycin—ocular cancer	0.00203	0.00659	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle—TFDP1—ocular cancer	0.00203	0.00294	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.00195	0.00283	CbGpPWpGaD
Ciprofloxacin—Myalgia—Dactinomycin—ocular cancer	0.00194	0.00627	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00193	0.0028	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.00192	0.00277	CbGpPWpGaD
Ciprofloxacin—Discomfort—Dactinomycin—ocular cancer	0.00191	0.00619	CcSEcCtD
Ciprofloxacin—Oedema—Dactinomycin—ocular cancer	0.00186	0.00601	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle—CCND3—ocular cancer	0.00184	0.00266	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—E2F1—ocular cancer	0.00184	0.00266	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00183	0.00264	CbGpPWpGaD
Ciprofloxacin—Thrombocytopenia—Dactinomycin—ocular cancer	0.00182	0.00588	CcSEcCtD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	0.00178	0.00257	CbGpPWpGaD
Ciprofloxacin—Anorexia—Dactinomycin—ocular cancer	0.00177	0.00573	CcSEcCtD
Ciprofloxacin—TOP2A—Circadian rythm related genes—CDK4—ocular cancer	0.00175	0.00254	CbGpPWpGaD
Ciprofloxacin—Musculoskeletal discomfort—Dactinomycin—ocular cancer	0.00169	0.00548	CcSEcCtD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	0.00163	0.00236	CbGpPWpGaD
Ciprofloxacin—Decreased appetite—Dactinomycin—ocular cancer	0.00161	0.00522	CcSEcCtD
Ciprofloxacin—Fatigue—Dactinomycin—ocular cancer	0.0016	0.00518	CcSEcCtD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	0.00159	0.0023	CbGpPWpGaD
Ciprofloxacin—Pain—Dactinomycin—ocular cancer	0.00159	0.00514	CcSEcCtD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—ocular cancer	0.00156	0.00225	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—CDK6—ocular cancer	0.00153	0.00222	CbGpPWpGaD
Ciprofloxacin—Feeling abnormal—Dactinomycin—ocular cancer	0.00153	0.00495	CcSEcCtD
Ciprofloxacin—Gastrointestinal pain—Dactinomycin—ocular cancer	0.00152	0.00491	CcSEcCtD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	0.00151	0.00218	CbGpPWpGaD
Ciprofloxacin—Body temperature increased—Dactinomycin—ocular cancer	0.00147	0.00475	CcSEcCtD
Ciprofloxacin—Abdominal pain—Dactinomycin—ocular cancer	0.00147	0.00475	CcSEcCtD
Ciprofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	0.00146	0.00211	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—CDK6—ocular cancer	0.00137	0.00198	CbGpPWpGaD
Ciprofloxacin—Hypersensitivity—Dactinomycin—ocular cancer	0.00137	0.00443	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.00136	0.00196	CbGpPWpGaD
Ciprofloxacin—Asthenia—Dactinomycin—ocular cancer	0.00133	0.00431	CcSEcCtD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—CCND2—ocular cancer	0.00132	0.00191	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.00132	0.00191	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—ocular cancer	0.0013	0.00189	CbGpPWpGaD
Ciprofloxacin—Diarrhoea—Dactinomycin—ocular cancer	0.00127	0.00411	CcSEcCtD
Ciprofloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—ocular cancer	0.00125	0.00181	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.00124	0.00179	CbGpPWpGaD
Ciprofloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	0.00121	0.00175	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.00118	0.00171	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.00118	0.00171	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—CCND2—ocular cancer	0.00118	0.00171	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—HDAC1—ocular cancer	0.00118	0.00171	CbGpPWpGaD
Ciprofloxacin—Vomiting—Dactinomycin—ocular cancer	0.00118	0.00382	CcSEcCtD
Ciprofloxacin—Rash—Dactinomycin—ocular cancer	0.00117	0.00379	CcSEcCtD
Ciprofloxacin—CYP3A7—Metabolism—PSPH—ocular cancer	0.00116	0.00168	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.00114	0.00165	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Tryptophan metabolism—MDM2—ocular cancer	0.00111	0.00161	CbGpPWpGaD
Ciprofloxacin—Nausea—Dactinomycin—ocular cancer	0.0011	0.00357	CcSEcCtD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.00109	0.00157	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—E2F1—ocular cancer	0.00109	0.00157	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—CDKN2B—ocular cancer	0.00106	0.00153	CbGpPWpGaD
Ciprofloxacin—TOP2A—Circadian rythm related genes—EP300—ocular cancer	0.00104	0.00151	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	0.00102	0.00147	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	0.00102	0.00147	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—E2F1—ocular cancer	0.000971	0.0014	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000947	0.00137	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000944	0.00137	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	0.000937	0.00136	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—CDK2—ocular cancer	0.000936	0.00135	CbGpPWpGaD
Ciprofloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	0.000926	0.00134	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	0.000892	0.00129	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—ocular cancer	0.000892	0.00129	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—ocular cancer	0.000885	0.00128	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.000859	0.00124	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—PSPH—ocular cancer	0.000839	0.00121	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—CDK2—ocular cancer	0.000837	0.00121	CbGpPWpGaD
Ciprofloxacin—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.000837	0.00121	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.000804	0.00116	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—CDK4—ocular cancer	0.000791	0.00114	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000778	0.00112	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.000777	0.00112	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	0.000775	0.00112	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—RB1—ocular cancer	0.000769	0.00111	CbGpPWpGaD
Ciprofloxacin—TOP2A—Circadian rythm related genes—TP53—ocular cancer	0.000746	0.00108	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000738	0.00107	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—RB1—ocular cancer	0.000688	0.000995	CbGpPWpGaD
Ciprofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000657	0.00095	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000637	0.000921	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—PSPH—ocular cancer	0.000633	0.000915	CbGpPWpGaD
Ciprofloxacin—ABCB1—Allograft Rejection—TGFB1—ocular cancer	0.00063	0.000912	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.00061	0.000883	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000602	0.000871	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.000599	0.000866	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—MDM2—ocular cancer	0.000587	0.000848	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000571	0.000827	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.000553	0.0008	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—CDKN1B—ocular cancer	0.000536	0.000775	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—EP300—ocular cancer	0.000526	0.000761	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—CCND1—ocular cancer	0.000511	0.000739	CbGpPWpGaD
Ciprofloxacin—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.000506	0.000732	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—PSPH—ocular cancer	0.000505	0.000731	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—CDKN1A—ocular cancer	0.000494	0.000715	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—EP300—ocular cancer	0.00047	0.00068	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle, Mitotic—MYC—ocular cancer	0.000458	0.000663	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000446	0.000645	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—MYC—ocular cancer	0.00041	0.000593	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000407	0.000589	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—PSPH—ocular cancer	0.00039	0.000564	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000389	0.000562	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000376	0.000544	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—GNA11—ocular cancer	0.000365	0.000528	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000358	0.000517	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—GNAQ—ocular cancer	0.000339	0.000491	CbGpPWpGaD
Ciprofloxacin—TOP2A—Cell Cycle—TP53—ocular cancer	0.000337	0.000487	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000312	0.000451	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000311	0.00045	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—GNA11—ocular cancer	0.000264	0.000382	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000256	0.00037	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—GNAQ—ocular cancer	0.000245	0.000355	CbGpPWpGaD
Ciprofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000216	0.000313	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—GNA11—ocular cancer	0.000199	0.000288	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—GNAQ—ocular cancer	0.000185	0.000268	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—GNA11—ocular cancer	0.000159	0.00023	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—GNAQ—ocular cancer	0.000148	0.000214	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—GNA11—ocular cancer	0.000123	0.000177	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—EP300—ocular cancer	0.000122	0.000176	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000119	0.000173	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—GNAQ—ocular cancer	0.000114	0.000165	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—EP300—ocular cancer	8.82e-05	0.000128	CbGpPWpGaD
Ciprofloxacin—CYP3A7—Metabolism—AKT1—ocular cancer	7.37e-05	0.000107	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—EP300—ocular cancer	6.65e-05	9.62e-05	CbGpPWpGaD
Ciprofloxacin—CYP3A5—Metabolism—AKT1—ocular cancer	5.33e-05	7.71e-05	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—EP300—ocular cancer	5.31e-05	7.68e-05	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—EP300—ocular cancer	4.1e-05	5.93e-05	CbGpPWpGaD
Ciprofloxacin—ABCB1—Metabolism—AKT1—ocular cancer	4.02e-05	5.82e-05	CbGpPWpGaD
Ciprofloxacin—CYP1A2—Metabolism—AKT1—ocular cancer	3.21e-05	4.64e-05	CbGpPWpGaD
Ciprofloxacin—CYP3A4—Metabolism—AKT1—ocular cancer	2.48e-05	3.58e-05	CbGpPWpGaD
